Profile for Finland Patent: C20250026
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Finland Patent: C20250026
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| ⤷ Start Trial | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| ⤷ Start Trial | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
